Meanwhile, PPVI also exerts the anti-NSCLC effect by inducing apoptosis through the phosphatidylinositol-3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway [75]. This evidence concerns the gene MTOR and non-small cell lung carcinoma.